Based on the Artivion Inc stock forecast from 6 analysts, the average analyst target price for Artivion Inc is USD 32.14 over the next 12 months. Artivion Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Artivion Inc is Slightly Bearish, which is based on 3 positive signals and 6 negative signals. At the last closing, Artivion Inc’s stock price was USD 30.96. Artivion Inc’s stock price has changed by +0.98% over the past week, +8.29% over the past month and +85.17% over the last year.
No recent analyst target price found for Artivion Inc
No recent average analyst rating found for Artivion Inc
Company Overview Artivion Inc
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary procedures; cardiac preservation services; PhotoFix, a bovine pericardial patch; and aortic arch stent grafts including E-vita Open Plus and E-vita Open Neo. It offers E-xtra design engineering systems for the treatment of aortic vascular diseases; E-nside, an off-the-shelf stent graft for the treatment of thoraco-abdominal disease; E-vita THORACIC 3G for the endovascular treatment of thoracic aortic aneurysms; E-ventus BX, a balloon-expandable peripheral stent graft for the endovascular treatment of renal and pelvic arteries; E-liac to treat aneurysmal iliac arteries, and aneurysmal iliac side branches; and E-tegra, a stent graft system for the treatment of infrarenal abdominal aortic aneurysms. In addition, the company offers synthetic vascular grafts for use in open aortic and peripheral vascular surgical procedures; PerClot, an absorbable powdered hemostat for use in surgical procedures; cardiac laser therapy products for angina treatment; CryoVein femoral vein and CryoArtery femoral artery vascular preservation services; On-X prosthetic aortic and mitral heart valves and the On-X ascending aortic prosthesis; CarbonAid CO2 diffusion catheters and Chord-X ePTFE sutures for mitral chordal replacement; and ascyrus medical dissection stents, as well as pyrolytic carbon coating services to medical device manufacturers. It serves physicians, hospitals, and other healthcare facilities, as well as cardiac, vascular, thoracic, and general surgeons. The company was formerly known as CryoLife, Inc. and changed its name to Artivion, Inc. in January 2022. Artivion, Inc. was incorporated in 1984 and is headquartered in Kennesaw, Georgia. Read Less
Artivion, Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company provides BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins for cardiac, vascular, neurologic, and pulmonary pro...Read More
Frequently Asked Questions About Artivion Inc (AORT) Stock
Based on ratings from 6 analysts Artivion Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 14 buy, sell and hold ratings.
Unfortunately we do not have enough data on AORT's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for AORT is USD 32.14 over the next 12 months. The maximum analyst target price is USD 37 while the minimum anlayst target price is USD 28.
AORT stock's Price/Earning ratio is 422.62.
Our analysis grades AORT stock's Price / Earning ratio at F. This means that AORT stock's Price/Earning ratio is above 90% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this AORT may be a overvalued for its sector.
The last closing price of AORT's stock was USD 30.96.
The most recent market capitalization for AORT is USD 1.17B.
Based on targets from 6 analysts, the average taret price for AORT is projected at USD 32.14 over the next 12 months.
This means that AORT's stock price may go up by +3.82% over the next 12 months.
We can't find any ETFs which contains Artivion Inc's stock.
As per our most recent records Artivion Inc has 1,500 Employees.
Artivion Inc's registered address is 1655 Roberts Boulevard N.W., Kennesaw, GA, United States, 30144.
You can get more information about it from Artivion Inc's website at https://artivion.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Positive free cash flow
The company had positive total free cash flow in the most recent four quarters.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Highly leveraged
The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.
Overpriced on free cash flow basis
The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Frequently Asked Questions About Artivion Inc (AORT) Stock
Based on ratings from 6 analysts Artivion Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Slightly Bearish. The stock has 14 buy, sell and hold ratings.
Unfortunately we do not have enough data on AORT's stock to indicate if its a good dividend stock.
Based on targets from 6 analysts, the average taret price for AORT is USD 32.14 over the next 12 months. The maximum analyst target price is USD 37 while the minimum anlayst target price is USD 28.
AORT stock's Price/Earning ratio is 422.62.
Our analysis grades AORT stock's Price / Earning ratio at F. This means that AORT stock's Price/Earning ratio is above 90% of the stocks in the Medical Devices sector in the NYE exchange.
Based on this AORT may be a overvalued for its sector.
The last closing price of AORT's stock was USD 30.96.
The most recent market capitalization for AORT is USD 1.17B.
Based on targets from 6 analysts, the average taret price for AORT is projected at USD 32.14 over the next 12 months.
This means that AORT's stock price may go up by +3.82% over the next 12 months.
We can't find any ETFs which contains Artivion Inc's stock.
As per our most recent records Artivion Inc has 1,500 Employees.
Artivion Inc's registered address is 1655 Roberts Boulevard N.W., Kennesaw, GA, United States, 30144.
You can get more information about it from Artivion Inc's website at https://artivion.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for AORT !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
